Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate pMDI Safety and Efficacy in COPD
NCT01176903Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Aug 2010; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01176903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176903.